Back

Charting the Circulating Proteome in ME/CFS: Cross System Profiling and Mechanistic insights

Hoel, A.; Hoel, F.; Dyrstad, S. E. F.; Chapola, H.; Rekeland, I. G.; Risa, K.; Alme, K.; Sorland, K.; Brokstad, K. A.; Marti, H.-P.; Mella, O.; Fluge, O.; Tronstad, K. J.

2025-05-31 infectious diseases Community evaluation
10.1101/2025.05.28.25328245 medRxiv
Show abstract

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a debilitating condition often triggered by infections. The underlying mechanism remains poorly understood, and diagnostic markers and effective treatments are presently lacking. We performed aptamer-based serum proteomics in 54 ME/CFS patients and 27 healthy controls and identified 1823 of 7326 aptamers reporting differences between the groups (845 after false discovery rate (FDR) correction). Distinct patterns of tissue- and process-specific changes were seen. There was a broad increase in secreted proteins, while intracellular proteins, e.g. from skeletal muscle, particularly showed reduction. Immune cell-specific signatures indicated immune reprogramming, including a distinct reduction in neutrophil-associated proteins. Focused secretome analysis supported intensified regulatory interactions related to immune activity, inflammation, vasculature, and metabolism. Validation of measurements using antibody-based methods confirmed findings for a selection of proteins. The uncovered serum proteome patterns in ME/CFS patients help clarify a multifaceted pathophysiology and offer a foundation for future therapy and biomarker discovery efforts.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.